Matches in Nanopublications for { ?s ?p "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP118424.RAl0jwV_EWrBazjDvZ4003e5eOBGCEs1iBp2CiTOHFIQo130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118424.RAl0jwV_EWrBazjDvZ4003e5eOBGCEs1iBp2CiTOHFIQo130_provenance.
- NP118427.RAlfBp40mDv7XTnamY5ytDe3e3pJYByBcDg3paUbLIcF8130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118427.RAlfBp40mDv7XTnamY5ytDe3e3pJYByBcDg3paUbLIcF8130_provenance.
- NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181624.RASkI-NlMHBzqI_ASetSLtio-tIV2k4bmmtx_MvkHLdYo130_provenance.
- NP181621.RAC0ttrWtUn0a15kj5La3xduvU6JA_eovGluK-MofE-eo130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181621.RAC0ttrWtUn0a15kj5La3xduvU6JA_eovGluK-MofE-eo130_provenance.
- assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP231404.RA6zSLV8yzYUPVy2iCrPl6HA7O_N7uZLxx_wPYqqUw61c130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231404.RA6zSLV8yzYUPVy2iCrPl6HA7O_N7uZLxx_wPYqqUw61c130_provenance.
- NP231403.RATqqFytAjIOFAdC8rgAKEqMUx3_X8KHezkjBtMctuvwE130_assertion description "[The CDKIs p16 and p27 are associated with tumour progression in melanoma, but do not reliably predict recurrence or survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231403.RATqqFytAjIOFAdC8rgAKEqMUx3_X8KHezkjBtMctuvwE130_provenance.